David Engelhardt

David Engelhardt has been employed in equity research at TraderFox GmbH since April 2022. David completed his Bachelor's degree in Economics at Friedrich-Alexander-University in Erlangen-Nuremberg in 2018 and subsequently obtained a Master's degree in Business Administration at the University of Bamberg. Since 2019, he has been independently engaged with the topics of stock markets, equities, and capital markets. For the equity magazine, he is mainly responsible for the Hot News section and regularly publishes his own articles there. Since March 2023, he has been reporting as the editor-in-chief for the Traderfox equity magazine Small Caps Investor about small companies with enormous growth potential.

Latest from David Engelhardt

Par Pacific Holdings: From Regional Oil Supplier to Green Fuel Pioneer

Par Pacific occupies high-margin, geographically isolated markets like Hawaii with high barriers to...

FIGS: Revolution in the Hospital Hallway - Rethinking Medical Apparel

FIGS is revolutionizing the outdated market for medical workwear by combining functional, athletic...

Phillips 66: Substantive Energy Stock with Future Prospects

As a leading downstream energy company, Phillips 66 refines crude oil at its own refineries and sells...

Twilio: The Return of a Tech Pioneer: How the Company Dominates Digital Communication

Twilio is the leading provider of cloud communication, enabling businesses to integrate SMS, telephony,...

Kodiak Sciences: Tackling the Global Blindness Threat

Kodiak Sciences is developing innovative biologics for the treatment of serious retinal diseases leading...

Halozyme Therapeutics: The License to Print Money: Why This Biotech Stock Is Not a Risky Bet

Halozyme operates not as a speculative drug developer, but as a highly profitable licensing company...

Iovance Biotherapeutics: The Pioneer of Personalized Cancer Therapy on the Brink of Breakthrough

Iovance Biotherapeutics has a first-mover advantage, as the company has commercialized Amtagvi, the...

Target Hospitality: How the Company is Capitalizing on the Infrastructure Boom

Target Hospitality builds and operates turnkey, modular housing facilities for professionals in remote...

AMD: The Rise into the Trillion-Dollar Club

AMD is fully focused on the design of cutting-edge processors and has them manufactured cost-effectively...

Illumina: The Indestructible Foundation of Gene Code Decoding

Illumina secures highly profitable, recurring revenues through the sale of gene sequencing machines...

Semtech: The Unassuming Winner in the Shadow of AI Giants

Semtech benefits disproportionately from the expansion of modern data centers, as its specialized...

CoreCivic: Here's how the Prison Operator is Cashing in on State Infrastructure Bottlenecks

CoreCivic earns its revenue through long-term contracts with U.S. authorities via per diem rates and...

Dell: From PC Pioneer to Powerhouse of the AI Age

Dell Technologies has transformed from a traditional PC manufacturer to a central and essential infrastructure...

Frequency Electronics: Precision Provider in the Shadow of the Space Explosion

Frequency Electronics is a highly specialized US manufacturer of atomic-accurate time and frequency...

Guardant Health: Cancer Detection via Blood Sample - Here's how the Company is Revolutionizing the Diagnostic Market

Guardant Health is a pioneer in liquid-based cancer testing, detecting genetic tumor traces painlessly...

Pulse Biosciences: Precision Strikes in the Nanosecond Range: how the Company is Revolutionizing Medicine

Pulse Biosciences has developed a highly precise, non-thermal method called Nanosecond Pulsed Field...

PBF Energy: The Crude Oil Refiner - How to Squeeze Clean Returns from Dirty Oil

PBF Energy focuses completely on the refining of crude oil and downstream logistics as an independent...

Delek US Holdings: Between Refining Margins, Midstream Stability, and Strategic Change

Delek US primarily generates its revenue in the refining business through the margin between crude...

Kymera Therapeutics: The Biotech Company Is Taking on Billion-Dollar Markets with Targeted Protein Destruction

Through targeted protein degradation, Kymera utilizes a biological recycling system that completely...

Marathon Petroleum: The Underestimated Cash Flow Machine of the US Stock Market

Marathon Petroleum is the largest independent refinery operator in the USA, primarily earning its...